REPLIGEN CORP — Director's Dealing 2019

Dec 9, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2019-12-05

Reporting Person: Snodgres Jon (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-05	Common Stock	M	2000	$24.50	Acquired	30239	Direct
2019-12-05	Common Stock	M	1957	$26.05	Acquired	32196	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-05	Stock Option (Right to Buy)	$24.50	M	2000	Disposed	2024-07-14	Common Stock (2000)	Direct
2019-12-05	Stock Option (Right to Buy)	$26.05	M	1957	Disposed	2026-02-26	Common Stock (1957)	Direct

Footnotes

F1: This option is currently exercisable.